Signature of circular RNAs in peripheral blood mononuclear cells from patients with active tuberculosis.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
03 2019
Historique:
received: 17 09 2018
revised: 13 11 2018
accepted: 22 11 2018
pubmed: 20 12 2018
medline: 26 6 2020
entrez: 20 12 2018
Statut: ppublish

Résumé

The study was to characterize the expression profiles of circular RNAs (circRNAs) in peripheral blood mononuclear cells (PBMCs) from active tuberculosis (TB) patients and to investigate their function. Microarray was applied to detect circRNA expression and reverse transcription-quantitative polymerase chain reaction was conducted to validate the microarray results. Meanwhile, receiver operating characteristic curve (ROC) curve was calculated to evaluate the predictive power of the selected circRNAs for TB diagnosis. Additionally, circRNA/miRNA interaction was predicted based on miRNA target prediction software, and gene ontology as well as Kyoto Encyclopedia of Genes and Genomes pathway analysis were used to predict their biological function. In total, 171 circRNAs were found to be dysregulated in TB samples. Specifically, circRNA_103017, circRNA_059914 and circRNA_101128 were confirmed to be increased, while circRNA_062400 was decreased in TB samples. ROC analysis revealed that circRNA_103017 had potential value for TB diagnosis, followed by circRNA_059914 and circRNA_101128. Moreover, circRNA_101128 expression in TB samples was negatively correlated with the level of its possible target let-7a and bioinformatics analysis showed that circRNA_101128 was potentially involved in MAPK and P13K-Akt pathway possibly via modulation of let-7a. Taken together, our results indicated that some dysregulated circRNAs were potential biomarkers for the diagnosis of TB and circRNA_101128-let-7a interplay may play considerable role in PBMCs response to Mtb infection.

Identifiants

pubmed: 30565391
doi: 10.1111/jcmm.14093
pmc: PMC6378186
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0
RNA, Circular 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Banques de données

GENBANK
['GSE117563']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1917-1925

Informations de copyright

© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Références

Mol Immunol. 2017 Oct;90:264-272
pubmed: 28846924
Cancer Lett. 2018 Aug 28;430:179-192
pubmed: 29803789
Int J Infect Dis. 2017 Jun;59:110-117
pubmed: 28416440
Lancet. 2017 Jul 15;390(10091):324-332
pubmed: 28139255
Nat Commun. 2017 Mar 06;8:14642
pubmed: 28262681
Mol Genet Metab. 2015 Dec;116(4):269-74
pubmed: 26527160
Nat Commun. 2018 Jul 16;9(1):2733
pubmed: 30013160
Sci Rep. 2018 Feb 5;8(1):2375
pubmed: 29403024
Cell Host Microbe. 2015 Mar 11;17(3):345-356
pubmed: 25683052
Blood Cancer J. 2016 Oct 14;6(10):e483
pubmed: 27740630
J Pathog. 2016;2016:8623825
pubmed: 27999684
Onco Targets Ther. 2018 Jul 10;11:3979-3987
pubmed: 30022841
Int J Mol Med. 2018 May;41(5):2885-2892
pubmed: 29436601
Microbiol Immunol. 2016 Apr;60(4):215-27
pubmed: 26876933
J Cell Mol Med. 2018 Sep;22(9):4076-4084
pubmed: 29961269
Cell Physiol Biochem. 2018;45(3):1230-1240
pubmed: 29448254
BMC Cancer. 2017 Mar 16;17(1):201
pubmed: 28302118
Science. 2017 Sep 22;357(6357):
pubmed: 28798046
BMC Microbiol. 2014 Feb 12;14:37
pubmed: 24521422
EBioMedicine. 2018 Jan;27:18-26
pubmed: 29248507
J Cell Mol Med. 2019 Mar;23(3):1917-1925
pubmed: 30565391
Mol Cell. 2017 Jul 20;67(2):214-227.e7
pubmed: 28625552
Oncotarget. 2017 Nov 27;8(69):113571-113582
pubmed: 29371930
Med Sci Monit. 2018 Apr 24;24:2497-2507
pubmed: 29686222
BMC Genet. 2017 Dec 02;18(1):100
pubmed: 29197342
Biochem Biophys Res Commun. 2016 Feb 26;471(1):52-6
pubmed: 26845359

Auteurs

Yurong Fu (Y)

Department of Medical Microbiology of Clinical Medicine College, Weifang Medical University, Weifang, Shandong Province, China.
Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, Shandong Province, China.

Jindong Wang (J)

Department of Medical Microbiology of Clinical Medicine College, Weifang Medical University, Weifang, Shandong Province, China.

Jinjuan Qiao (J)

Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, Shandong Province, China.

Zhengjun Yi (Z)

Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, Shandong Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH